Microbiologist.in
Pharma QC microbiology, in your pocket
Published by International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Harmonised guidelines on quality, safety and efficacy adopted by regulators including the FDA, EMA, PMDA and CDSCO.
Why it matters to you: ICH quality (Q) guidelines shape specifications, validation, risk management and the quality system that your micro lab works within.
ICH guidelines are grouped into Quality (Q), Safety (S), Efficacy (E) and Multidisciplinary (M). For a QC microbiologist the Q series is what matters.
Once adopted by a regulator, an ICH guideline becomes that regulator's expectation. Revisions are shown as (R1), (R2) and so on, and the newest version replaces the older one.
ICH Q4B is especially useful: it records which pharmacopoeial chapters regulators accept as interchangeable across the USP, Ph. Eur. and JP.
Tap a reference to read what it covers and the points that matter in the lab.
Defines how stability studies are designed: storage conditions, testing frequency and the attributes to test, which include microbiological quality where relevant.
Describes the validation characteristics for analytical procedures, such as specificity, accuracy, precision, range and detection limit, and how to apply them.
Evaluates pharmacopoeial texts and recommends them as interchangeable in the ICH regions. Separate annexes cover microbial enumeration, specified organisms, acceptance criteria, sterility and bacterial endotoxins.
Viral safety of biotechnology products from cell lines: testing of cell banks and harvests, and validation of viral clearance steps.
How to set specifications for new chemical drug substances and products, including decision trees for when microbial limits testing is needed and which limits apply.
GMP for active pharmaceutical ingredients, covering the quality system, facilities, materials, production, laboratory controls and validation.
Principles and tools of quality risk management such as FMEA, HACCP and risk ranking, with the R1 revision addressing subjectivity and formality.
A model pharmaceutical quality system across the product lifecycle: process performance monitoring, CAPA, change management and management review.
Summarised in our own words for learning. Always refer to the current official text for exact requirements. How we use references